melitten and Contusions

melitten has been researched along with Contusions* in 1 studies

Other Studies

1 other study(ies) available for melitten and Contusions

ArticleYear
Melittin - A bee venom component - Enhances muscle regeneration factors expression in a mouse model of skeletal muscle contusion.
    Journal of pharmacological sciences, 2019, Volume: 140, Issue:1

    Melittin is a major peptide component of sweet bee venom that possesses anti-allergic, anti-inflammatory, anti-arthritis, anti-cancer, and neuroprotective properties. However, the therapeutic effects of melittin on muscle injury have not been elucidated. We investigated the therapeutic effects of melittin on muscle injury in a mouse model of muscle contusion. The biceps femoris muscle of the mice was injured using drop mass method, and the animals were treated with melittin (4, 20, or 100 μg/kg) for 7 days. Melittin significantly increased: locomotor activity in open field test, and treadmill running activity in a dose-dependent manner to level comparable to the positive control, diclofenac (30 mg/kg). Melittin treatment attenuated the pro-inflammatory cytokine MCP-1, TNF-α and IL-6. The expression of muscle regeneration biomarkers, including MyoD (muscle differentiation marker), myogenin, smooth muscle actin, and myosin heavy chain was markedly increased in the injured muscle tissue of melittin-treated mice, as determined by western blotting and quantitative real-time polymerase chain reaction. These results demonstrate that melittin inhibits inflammatory response and improves muscle damage by regenerating muscles in a mouse model of muscle contusion. Taken together, the results of present study suggest that melittin is a promising candidate for the muscle injury treatment.

    Topics: Actins; Animals; Anti-Inflammatory Agents; Bee Venoms; Chemokine CCL2; Contusions; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Inflammation Mediators; Interleukin-6; Male; Melitten; Mice, Inbred C57BL; Muscle, Skeletal; MyoD Protein; Myogenin; Myosin Heavy Chains; Regeneration; Tumor Necrosis Factor-alpha

2019